phase readout
saveNCT07336615: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals
ENROLLING_BY_INVITATIONupdated 1mo ago
community read0 votes
Sponsor: ClostraBio Inc.. Phase: NA. Conditions: Gastrointestinal, Overweight , Obesity
view source ↗
comments(0)
5-min edit window · permanent after that